Beijnen

Jos Beijnen

Anticancer drug development

Our group specialises in pharmacology and the development of anti cancer drugs.

 

More about this group

Our research

Team members

Beijnen Profiel
Jos Beijnen

Group leader
Pauline Buitelaar
Pauline Buitelaar

PhD student
NKI Placeholder Profiel
Wan-Yu Chu

PhD student
Maud Van Der Kleij
Maud van der Kleij

PhD student
Anke Leeuwerik
Anke Leeuwerik

PhD student
NKI Placeholder Profiel
Lishi Lin

PhD student
NKI Placeholder Profiel
Marinda Meertens

PhD student
NKI Placeholder Profiel
Dick Pluim

Analist
NKI Placeholder Profiel
Irene Retmana

PhD student
Hinke Siebinga
Hinke Siebinga

PhD student

News and stories

Highly Cited Researcher 2023

Five researchers from the Netherlands Cancer Institute recognized as highly cited researcher 2023

14-11-2023
Highly Cited Researchers 550X320

Five researchers from the Netherlands Cancer Institute recognized as highly cited researcher 2022

15-11-2022
Theses Defense Marie Rose Preview Photo 1

Thesis defense Marie-Rose Crombag anti-cancer drugs in the elderly

05-09-2019
More news

Publications of this group

Investigational new drugs

Extrahepatic metabolism of ibrutinib.

01-02-2021
Key Publication

Pharmacological research

Daraxonrasib (RMC-6236) pharmacokinetics: impact of transporters and drug-metabolizing enzymes on a first-in-class pan-RAS molecular glue.

01-07-2026
More publications

Our collaborations

Schematic structure and pharmacologically important drug transport functions (arrows) of the multidrug resistance protein ABCG2

Alfred Schinkel
Pre and post T1-Contrast-enhanced MRI image of a spontaneous high-grade glioma in mice

Olaf van Tellingen

Contact our group

NKI Placeholder Profiel
Sarah Stolk

Office Manager

Phone

Email

Learn more about our...

Facilities & Platforms
Researchers
Disclaimer
Privacy statement
Cookies
Change cookie settings